Medaphor Group PLC Notice of AGM (8149L)
April 24 2018 - 1:01AM
UK Regulatory
TIDMMED
RNS Number : 8149L
Medaphor Group PLC
24 April 2018
24 April 2018
MedaPhor Group plc
("MedaPhor" or the "Group" or the "Company")
Notice of Annual General Meeting
MedaPhor Group plc (AIM: MED), the intelligent ultrasound
software and simulation company, announces that the Company's
Annual General Meeting ("the AGM") will be held will be held at IP
Group Offices, The Walbrook Building, 25 Walbrook, London, EC4N 8AF
on 17 May 2018 at 10.30am.
The Group's 2017 Annual Report which contains the formal notice
of the AGM has today been posted on the Group's website,
www.medaphor.com. Hard copies of the Annual Report including the
Notice and a form of proxy for use at the AGM have been posted to
all shareholders.
Medaphor is committed to reducing paper and improving efficiency
in its shareholder communications. From 2019, the Company will no
longer be sending paper proxy cards to shareholders unless
specifically asked to do so. Advice on how to request a paper proxy
will be provided to shareholders at the appropriate time.
A copy of this announcement is available on the Group's website:
www.medaphor.com
Enquiries:
MedaPhor Group plc www.medaphor.com
Stuart Gall, CEO Tel: +44 (0)29 2075
Ian Whittaker, COO 6534
Cenkos Securities Tel: +44 (0)20 7397
8900
Camilla Hume/Bobbie Hilliam
(Nominated Advisor)
Michael Johnson / Julian
Morse (Corporate Broking)
Walbrook PR Tel: +44 (0)20 7933 8780 or
medaphor@walbrookpr.com
Paul McManus / Anna Mob: +44 (0)7980 541 893 / Mob:
Dunphy +44 (0)7876 741 001
About MedaPhor (www.investors.medaphor.com)
MedaPhor (AIM: MED), the intelligent ultrasound software and
simulation company, develops artificial intelligence-based clinical
image analysis software tools, augmented reality-based needle
guidance software and advanced hi-fidelity haptic and manikin-based
training simulators for medical practitioners.
Based in Cardiff and Oxford in the UK and Atlanta in the US and
Hong Kong in Asia, MedaPhor operates two divisions:
Intelligent Ultrasound Simulation Division
Focuses on hi-fidelity ultrasound education and training through
simulation. Its three main products are the ScanTrainer OBGYN and
General Medical simulator training platform, the HeartWorks
echocardiography simulator platform and the BodyWorks Eve Point of
Care and Emergency Medicine Simulator. Over 500 MedaPhor simulators
have been sold to over 300 medical institutions in over 30
countries around the world.
Intelligent Ultrasound Clinical Division
Focuses on augmented reality and deep-learning based algorithms
to make ultrasound machines smarter and more accessible. Products
in development include ScanNav which uses machine-learning based
algorithms to automatically identify and grade ultrasound images to
provide scan assessment and audit of obstetric scanning.
NeedleGuide aims to simplify ultrasound-guided needling by using
deep learning and augmented reality to provide the user with
pathway guidance and automated tracking for a range of medical
procedures.
Some products in the pipeline may require US FDA approval, as
such this material should be considered informational only and does
not constitute an offer to sell or infer claims or benefits.
This information is provided by RNS
The company news service from the London Stock Exchange
END
NOAUOOORWVASUAR
(END) Dow Jones Newswires
April 24, 2018 02:01 ET (06:01 GMT)
Intelligent Ultrasound (LSE:IUG)
Historical Stock Chart
From Jun 2024 to Jul 2024
Intelligent Ultrasound (LSE:IUG)
Historical Stock Chart
From Jul 2023 to Jul 2024